An important part of treating your allergic asthma is staying informed and surrounding yourself with community and valuable support. Although your doctor is the best source of information about your condition and treatment with XOLAIR, below are a handful of tools and resources we think you may find useful:
AsthmaMatters is a valuable resource for people living with allergic asthma. When you join the program, you’ll learn how to take a more active role in managing your condition. You’ll also receive:
- A personalized Doctor Discussion Guide
- A series of educational e-mails about allergic asthma and treatment
- Helpful interactive tools and tips as well as links to other online resources
Xpansions is a free patient support program created for people on treatment with XOLAIR and their caregivers. As a member, you’ll receive a welcome mailing and have access to:
- Xpansions.com: get helpful tips and tools, educational stories from other XOLAIR patients, and more
- Our informative, quarterly newsletter sent straight to your home. Get it now
- The XOLAIR Product Information Line: call 1-866-4XOLAIR (1-866-496-5247) to speak with a nurse educator who can help answer questions about your treatment with XOLAIR
Join the community designed specially for you. Sign up today
XOLAIR Access Solutions is a special team set up to help you and your doctor work through any issues with getting and starting XOLAIR. It provides assistance in 3 areas:
- 1. Coverage and reimbursement through a staff of dedicated experts
- 2. Patient assistance for people who are uninsured or financially challenged
- 3. Informational Resources, available to your doctor online or by phone, that provide more detail about being able to access XOLAIR
Learn more about XOLAIR Access Solutions. Go now
EXPECT XOLAIR Pregnancy Registry is a study that collects health information about women who are pregnant and have been treated with XOLAIR. It is used to provide patients and doctors with important information about the use of XOLAIR in pregnant women and their babies.
Pregnant or thinking of becoming pregnant?
If you've been treated with XOLAIR, you may be eligible to participate in the registry. Ask your doctor for more information, or simply visit www.XOLAIRpregnancyregistry.com.
Patient Resources
It's important to stay informed about XOLAIR and allergic asthma. Below are some materials, which you can download or print, to help you with the information you need.
Asthma Control Test™ (ACT)
Find out if your asthma is currently controlled. Take the ACT test now.
To view PDF files, Adobe® Reader® must be installed on your computer. If you do not have this program, click here to get it.
Adobe, the Adobe logo, and Reader are registered trademarks of Adobe Systems Incorporated in the United States and/or other countries.
WHO IS XOLAIR FOR?
XOLAIR® (Omalizumab) For Subcutaneous Use is a prescription medicine given by injection for people who are 12 years of age and above who have moderate to severe persistent asthma that is triggered by year-round allergens in the air. A simple skin or blood test will confirm that you have this kind of asthma. This is known as allergic asthma. XOLAIR helps reduce the number of asthma attacks in people with allergic asthma who still have asthma symptoms even though they are taking inhaled steroids. XOLAIR has not been proven to work in other allergic conditions.
Important Safety Information
XOLAIR should always be injected in a doctor's office. You should read the Medication Guide before starting XOLAIR treatment and before each and every treatment.
A severe allergic reaction called anaphylaxis has happened in some patients after they received XOLAIR. Anaphylaxis is a life-threatening condition. Seek emergency medical treatment right away if symptoms occur. Signs and symptoms of anaphylaxis include:
- Wheezing, shortness of breath, cough, chest tightness, or trouble breathing
- Low blood pressure, dizziness, fainting, rapid or weak heartbeat, anxiety, or feeling of "impending doom"
- Flushing, itching, hives, or feeling warm
- Swelling of the throat or tongue, throat tightness, hoarse voice, or trouble swallowing
You should not receive XOLAIR if you have ever had an allergic reaction to a XOLAIR injection. Do not use XOLAIR if you are allergic to any of its ingredients.
In clinical studies 0.5% of patients receiving XOLAIR developed cancer, compared to 0.2% of patients receiving placebo injections.
In clinical studies, the most common side effects in patients receiving XOLAIR included injection-site reactions (45%), viral infections (23%), upper respiratory tract infection (20%), sinusitis (16%), headache (15%), and sore throat (11%).
Do not change or stop taking any of your other asthma medicines unless your healthcare provider tells you to do so. You may not see an immediate improvement in your asthma when beginning XOLAIR therapy.
Talk to your doctor for more information and if you have any questions about your treatment.
Please see full Prescribing Information and the Medication Guide for additional important information.
This Web site is a service of Genentech, Inc., and Novartis Pharmaceuticals Corporation.
This site is intended for U.S. residents only.